These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 22433837

  • 1. Blockade of pro-cognitive effects of angiotensin IV and physostigmine in mice by oxytocin antagonism.
    Gard PR, Naylor C, Ali S, Partington C.
    Eur J Pharmacol; 2012 May 15; 683(1-3):155-60. PubMed ID: 22433837
    [Abstract] [Full Text] [Related]

  • 2. Interactions of angiotensin IV and oxytocin on behaviour in mice.
    Gard PR, Daw P, Mashhour ZS, Tran P.
    J Renin Angiotensin Aldosterone Syst; 2007 Sep 15; 8(3):133-8. PubMed ID: 17907101
    [Abstract] [Full Text] [Related]

  • 3. Assessment of biological activity of novel peptide analogues of angiotensin IV.
    Gard PR, Olivier G, Golding B, Bourner C, Dang T, Haliru H, Higgins E, Kimberley H, Loginova O, Madhavi S, Ryan D.
    J Pharm Pharmacol; 2011 Apr 15; 63(4):565-71. PubMed ID: 21401609
    [Abstract] [Full Text] [Related]

  • 4. Physostigmine reverses cognitive dysfunction caused by moderate hypoxia in adult mice.
    Bekker A, Haile M, Gingrich K, Wenning L, Gorny A, Quartermain D, Blanck T.
    Anesth Analg; 2007 Sep 15; 105(3):739-43. PubMed ID: 17717233
    [Abstract] [Full Text] [Related]

  • 5. Involvement of central cholinergic mechanisms in the effects of oxytocin and an oxytocin receptor antagonist on retention performance in mice.
    Boccia MM, Baratti CM.
    Neurobiol Learn Mem; 2000 Nov 15; 74(3):217-28. PubMed ID: 11031128
    [Abstract] [Full Text] [Related]

  • 6. Strain differences in the effects of angiotensin IV on mouse cognition.
    Golding BJ, Overall AD, Brown G, Gard PR.
    Eur J Pharmacol; 2010 Sep 01; 641(2-3):154-9. PubMed ID: 20553916
    [Abstract] [Full Text] [Related]

  • 7. Effects of a single administration of oxytocin or vasopressin and their interactions with two selective receptor antagonists on memory storage in mice.
    Boccia MM, Kopf SR, Baratti CM.
    Neurobiol Learn Mem; 1998 Mar 01; 69(2):136-46. PubMed ID: 9619993
    [Abstract] [Full Text] [Related]

  • 8. Decreased behavioural and neurochemical effects of angiotensin IV following prenatal alcohol exposure in the mouse.
    Fidalgo S, Patel M, Quadir A, Sadiq W, Gard PR.
    Neuropeptides; 2019 Oct 01; 77():101931. PubMed ID: 31079845
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. SLV330, a cannabinoid CB1 receptor antagonist, ameliorates deficits in the T-maze, object recognition and Social Recognition Tasks in rodents.
    de Bruin NM, Prickaerts J, Lange JH, Akkerman S, Andriambeloson E, de Haan M, Wijnen J, van Drimmelen M, Hissink E, Heijink L, Kruse CG.
    Neurobiol Learn Mem; 2010 May 01; 93(4):522-31. PubMed ID: 20132903
    [Abstract] [Full Text] [Related]

  • 11. Therapeutic targeting of insulin-regulated aminopeptidase: heads and tails?
    Albiston AL, Peck GR, Yeatman HR, Fernando R, Ye S, Chai SY.
    Pharmacol Ther; 2007 Dec 01; 116(3):417-27. PubMed ID: 17900701
    [Abstract] [Full Text] [Related]

  • 12. Effects of the non-peptide B2 antagonist FR173657 on kinin-induced smooth muscle contraction and relaxation, vasoconstriction and prostaglandin release.
    Griesbacher T, Sametz W, Legat FJ, Diethart S, Hammer S, Juan H.
    Br J Pharmacol; 1997 Jun 01; 121(3):469-76. PubMed ID: 9179388
    [Abstract] [Full Text] [Related]

  • 13. General pharmacological profile of the novel cholecystokinin-A antagonist loxiglumide.
    Saito T, Ukai K, Masuda T, Nakagawa T, Kimura K, Fujii M, Wakatsuki K, Saeki M, Kasai H.
    Arzneimittelforschung; 1997 Dec 01; 47(12):1375-82. PubMed ID: 9450167
    [Abstract] [Full Text] [Related]

  • 14. D2 dopamine receptor blockade prevents cognitive effects of Ang IV and des-Phe6 Ang IV.
    Braszko JJ.
    Physiol Behav; 2006 Jun 15; 88(1-2):152-9. PubMed ID: 16690090
    [Abstract] [Full Text] [Related]

  • 15. Blockade of the effects of angiotensin, oxytocin, norepinephrine, 5-hydroxytryptamine and acetylcholine by guancydine.
    Worcel M, Papadimitriou A, Meyer P.
    J Pharmacol Exp Ther; 1971 Oct 15; 179(1):42-6. PubMed ID: 4328887
    [No Abstract] [Full Text] [Related]

  • 16. Effect of D(3) dopamine receptors blockade on the cognitive effects of angiotensin IV in rats.
    Braszko JJ, Wielgat P, Walesiuk A.
    Neuropeptides; 2008 Jun 15; 42(3):301-9. PubMed ID: 18359517
    [Abstract] [Full Text] [Related]

  • 17. Disulfide cyclized tripeptide analogues of angiotensin IV as potent and selective inhibitors of insulin-regulated aminopeptidase (IRAP).
    Andersson H, Demaegdt H, Vauquelin G, Lindeberg G, Karlén A, Hallberg M, Erdélyi M, Hallberg A.
    J Med Chem; 2010 Nov 25; 53(22):8059-71. PubMed ID: 21047126
    [Abstract] [Full Text] [Related]

  • 18. Antidepressant-like effects of oxytocin in mice are dependent on the presence of insulin-regulated aminopeptidase.
    Loyens E, De Bundel D, Demaegdt H, Chai SY, Vanderheyden P, Michotte Y, Gard P, Smolders I.
    Int J Neuropsychopharmacol; 2013 Jun 25; 16(5):1153-63. PubMed ID: 23177092
    [Abstract] [Full Text] [Related]

  • 19. The effect of D-amphetamine and physostigmine upon acquisition and retrieval in a single trial learning task.
    Bohdanecky Z, Jarvik ME.
    Arch Int Pharmacodyn Ther; 1967 Nov 25; 170(1):58-65. PubMed ID: 6056593
    [No Abstract] [Full Text] [Related]

  • 20. Central administration of angiotensin IV rapidly enhances novel object recognition among mice.
    Paris JJ, Eans SO, Mizrachi E, Reilley KJ, Ganno ML, McLaughlin JP.
    Neuropharmacology; 2013 Jul 25; 70():247-53. PubMed ID: 23416700
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.